Providing leadership and expertise at the intersection of Lilly’s industry leading venture capital strategy and R&D. With goal to identify, propel and deliver innovation, I am driven by the opportunity to translate basic science to potential novel therapies for patients.Experienced drug hunting scientist and project leader with proven track record of discovering and developing new molecular entities in the biopharmaceutical industry. PhD trained molecular physiologist with deep therapeutic understanding of metabolic and endocrine disease landscape. Proven R&D leadership, serving as a trusted partner and corporate advisor to advance internal and external innovation, business development, and licensing initiatives. Self-motivated and task-oriented with excellent collaboration, decision making, and leadership skills. Extensive awareness of scientific literature and biopharmaceutical landscape, including novel MOAs, targets, and therapies. Excellent problem-solving skills and ability to effectively prioritize multiple complex tasks and projects with demonstrated personal and organizational EQ.